5-HT2C receptor sensitivity after chronic paroxetine administration in the presence or absence of the 5-HT1A receptor antagonist WAY100635

被引：0
|
作者：
Starr, KR [1 ]
Duxon, MS [1 ]
Upton, N [1 ]
机构：
[1] SmithKline Beecham Pharmaceut, Neurosci Res, Harlow CM19 5AD, Essex, England
来源：
EUROPEAN JOURNAL OF NEUROSCIENCE | 2000年 / 12卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：473 / 473
页数：1
相关论文
共 50 条
  • [21] EFFECTS OF ACUTE AND CHRONIC TREATMENT WITH THE SELECTIVE 5-HT1A RECEPTOR ANTAGONIST WAY-100635 ON HIPPOCAMPAL 5-HT RELEASE IN-VIVO
    GURLING, J
    ASHWORTHPREECE, MA
    DOURISH, CT
    ROUTLEDGE, C
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U152 - U152
  • [22] Effects of WAY100635, a selective 5-HT1A-receptor antagonist on the micturition-reflex pathway in the rat
    Kakizaki, H
    Yoshiyama, M
    Koyanagi, T
    De Groat, WC
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2001, 280 (05) : R1407 - R1413
  • [23] EFFECT OF THE PUTATIVE 5-HT1A ANTAGONIST WAY100635 ON 5-HT NEURONAL FIRING IN THE GUINEA-PIG DORSAL RAPHE NUCLEUS
    MUNDEY, MK
    FLETCHER, A
    MARSDEN, CA
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U49 - U49
  • [24] The effects of 5-HT1A and 5-HT2C receptor agonists on behavioral satiety sequence in rats
    Elsa Lopez-Alonso, Veronica
    Manuel Mancilla-Diaz, Juan
    Rito-Domingo, Melissa
    Gonzalez-Hernandez, Brenda
    Erick Escartin-Perez, Rodrigo
    NEUROSCIENCE LETTERS, 2007, 416 (03) : 285 - 288
  • [25] Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635
    Bagdy, G
    Graf, M
    Anheuer, ZE
    Modos, EA
    Kantor, S
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2001, 4 (04): : 399 - 408
  • [26] Effect of WAY100635, a 5-HT1A antagonist on cystometrograms and natural voiding in C57BL/6 mice
    Hu, DQ
    Tsung, S
    Nunn, P
    Ford, A
    Zhu, QM
    FASEB JOURNAL, 2003, 17 (04): : A649 - A649
  • [27] THE 5-HT2C/2B RECEPTOR ANTAGONIST SB-200646A IS A POTENT AND SELECTIVE ANTAGONIST OF THE HUMAN 5-HT2C RECEPTOR
    WOOD, MD
    GAGER, TL
    THOMAS, DR
    NEWTON, RA
    PHIPPS, SL
    ELLIOTT, JM
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 : P155 - P155
  • [28] Effects of 5-HT1A Receptor Antagonist and 5-HT2A Receptor Agonist on Morphine Withdrawal
    Ramezani, Mahdi
    Shahidi, Siamak
    Afshar, Simin
    Habibi, Parisa
    Hashemi-Firouzi, Nasrin
    NEUROCHEMICAL JOURNAL, 2024, 18 (02) : 321 - 330
  • [29] The TRY/WAY approach:: combined treatment with L-tryptophan and the 5-HT1A (auto)receptor antagonist WAY100635 increases 5-HT output in the rat frontal cortex but not in the dorsal hippocampus
    Bengtsson, HJ
    Peilot, H
    Hjorth, S
    NORDIC JOURNAL OF PSYCHIATRY, 1998, 52 (02) : 105 - 106
  • [30] Effect of reserpine on behavioural responses to agonists at 5-HT1A, 5-HT1B, 5-HT2A, and 5-HT2C receptor subtypes
    Heslop, KE
    Curzon, G
    NEUROPHARMACOLOGY, 1999, 38 (06) : 883 - 891
12345